亚洲图片国产日韩欧美_国产区精品欧美日韩在线蜜臀_韩国日本三级在线观看手机视频_影音先锋国产精品无码_亚洲日本va一区二区三区_亚洲精品无码丰满少妇av_天堂在线中文www_扒开粉嫩的小缝开始亲吻男女_尤蜜在线观看免费观看_久久毛片欧洲无码视频

×

本司產(chǎn)品僅用于科研,不用于臨床診斷和治療

全國(guó)免費(fèi)熱線:400-999-2100

您身邊的細(xì)胞培養(yǎng)專家!

所有分類
  • 所有分類
  • 細(xì)胞系
  • 原代細(xì)胞
  • 血清
  • 細(xì)胞培養(yǎng)基
  • 輔助試劑
  • 細(xì)胞凋亡檢測(cè)試劑盒
  • 細(xì)胞房除菌產(chǎn)品
熱搜: 胎牛血清 VERO RAW264.7 成纖維細(xì)胞 間充質(zhì)干細(xì)胞 上皮細(xì)胞

忘記密碼

個(gè)人郵箱:
驗(yàn)證碼: captcha

賬號(hào)激活

個(gè)人郵箱:
×

產(chǎn)品中心Cell Resources

聯(lián)系我們CONTACT US

  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)

PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)

貨號(hào):CL-0184

規(guī)格:1×10?cells/T25培養(yǎng)瓶

價(jià)格: ¥1600

生長(zhǎng)培養(yǎng)基:DMEM10% FBS1% P/S

數(shù)量: - +

  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
  • PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)

推薦搭配

套餐1:

PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確) ¥1600
PANC-1細(xì)胞專用培養(yǎng)基
  • ¥350
  • ¥450

現(xiàn)單獨(dú)購(gòu)買該產(chǎn)品也可享受限時(shí)優(yōu)惠價(jià)!

細(xì)胞培養(yǎng)最優(yōu)解!

套餐組合價(jià):¥1950¥2050

加入購(gòu)物車

搭配套餐已成功加入購(gòu)物車!

產(chǎn)品概述
產(chǎn)品信息
名稱 PANC-1 (人胰腺癌細(xì)胞) (STR鑒定正確)
別稱 Panc-1; PANC.1; Panc 1; PanC1; Panc1; PANC1; Panc-1-P
種屬
生長(zhǎng)特性 貼壁細(xì)胞
細(xì)胞形態(tài) 上皮細(xì)胞樣
凍存條件 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮
培養(yǎng)方案A(默認(rèn))
生長(zhǎng)培養(yǎng)基:
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
推薦傳代比例 1:2-1:4
推薦換液頻率 2-3次/周
參考資料(來(lái)源文獻(xiàn))
背景描述 這株人胰腺癌細(xì)胞株P(guān)ANC-1源自于胰腺癌導(dǎo)管細(xì)胞。PANC-1細(xì)胞倍增時(shí)間為52小時(shí),G6PD活性處于低泳動(dòng)性的B型。染色體研究表明,PANC-1細(xì)胞模式數(shù)目為63,包括3個(gè)獨(dú)特標(biāo)記的染色體和1個(gè)小環(huán)狀染色體。PANC-1細(xì)胞的生長(zhǎng)可被1U/ml的左旋天冬酰胺酶抑制;PANC-1細(xì)胞能在軟瓊脂上生長(zhǎng),亦能在裸鼠上成瘤。
年齡(性別) 男性;56歲
組織來(lái)源 胰腺;胰管;上皮細(xì)胞癌
細(xì)胞類型 腫瘤細(xì)胞
腫瘤類型 胰腺癌細(xì)胞
生物安全等級(jí) BSL-1
倍增時(shí)間 ~38-56 hours
保藏機(jī)構(gòu) ATCC; CRL-1469
STR鑒定
  • STR位點(diǎn)信息
    Amelogenin X
    CSF1PO 10,12
    D2S1338 23,24
    D3S1358 17
    D5S818 11,13
    D7S820 8,10
    D8S1179 14,15
    D13S317 11
    D16S539 11,12
    D18S51 12
    D19S433 11,16
    D21S11 28
    FGA 21
    PentaD 14
    PentaE 7,14
    TH01 7,8
    TPOX 8,11
    vWA 15
    D6S1043 11,12
    D12S391 22
    D2S441 10,14
  • STR鑒定圖
參考文獻(xiàn)
文獻(xiàn)列表
  • TRIM29 facilitates gemcitabine resistance via MEK/ERK pathway and is modulated by circRPS29/miR-770-5p axis in PDAC(2024/03/12)

    作者:Wenjie Huang, Xiaojun Hu, Xiang He

    期刊:DRUG RESISTANCE UPDATES

    DOI:10.1016/j.drup.2024.101079

    影響因子 :24.300

    引用產(chǎn)品:CL-0184

  • Dual-crosslinking immunostimulatory hydrogel synchronously suppresses pancreatic fistula and pancreatic cancer relapse post-resection(2023/12/24)

    作者:Ruizhi Zhao, Qiuqun Xiao, Yuanyuan Wu

    期刊:BIOMATERIALS

    DOI:10.1016/j.biomaterials.2023.122453

    影響因子 :14.000

    引用產(chǎn)品:CL-0184

  • ZMAT1 acts as a tumor suppressor in pancreatic ductal adenocarcinoma by inducing SIRT3/p53 signaling pathway(2022/04/07)

    作者:Ma Zuyi, Li Zhenchong, Wang Shujie

    期刊:JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

    DOI:10.1186/s13046-022-02310-8

    影響因子 :11.300

    引用產(chǎn)品:CL-0027 CL-0042 CL-0184 CL-0709

  • Elevated expression of the rhythm gene NFIL3 promotes the progression of TNBC by activating NF-κB signaling through suppression of NFKBIA transcription(2022/02/18)

    作者:Weiwei Yang , Jing Li, Minghui Zhang

    期刊:Journal Of Experimental & Clinical Cancer Research

    DOI:10.1186/s13046-022-02260-1

    影響因子 :11.300

    引用產(chǎn)品:CL-0016 CL-0041 CL-0097 CL-0101 CL-0114 CL-0184 CL-0215 CL-0525

  • SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis(2021/07/24)

    作者:Dianyun Ren, Yan Sun, Dan Zhang

    期刊:Cancer Letters

    DOI:10.1016/j.canlet.2021.07.035

    影響因子 :9.700

    引用產(chǎn)品:CL-0042 CL-0184

  • Concurrent inhibition of pBADS99 synergistically improves MEK inhibitor efficacy in KRASG12D-mutant pancreatic ductal adenocarcinoma(2024/02/26)

    作者:Yanqin Tan, Bowen Sun, Xi Zhang

    期刊:Cell Death & Disease

    DOI:10.1038/s41419-024-06551-7

    影響因子 :9.000

    引用產(chǎn)品:CL-0184

  • METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation(2023/03/28)

    作者:Chengjie Lin, Ting Li, Yan Wang

    期刊:Cell Death & Disease

    DOI:10.1038/s41419-023-05715-1

    影響因子 :9.000

    引用產(chǎn)品:CL-0042 CL-0184

  • HMGA2 alleviates ferroptosis by promoting GPX4 expression in pancreatic cancer cells(2024/03/16)

    作者:Ziyang Luo, Qingfang Zheng, Shazhou Ye

    期刊:Cell Death & Disease

    DOI:10.1038/s41419-024-06592-y

    影響因子 :9.000

    引用產(chǎn)品:CL-0184

  • Local Sustained Chemotherapy of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Injection of Biodegradable Thermo-Sensitive Hydrogel(2023/07/19)

    作者:Dan Yang, Jing Ning, Xiaomin Liao

    期刊:International Journal of Nanomedicine

    DOI:10.2147/IJN.S417445

    影響因子 :8.000

    引用產(chǎn)品:CL-0184

  • Diterpenoid honatisine overcomes temozolomide resistance in glioblastoma by inducing mitonuclear protein imbalance through disruption of TFAM-mediated mtDNA transcription(2023/12/29)

    作者:Zongyang Li, Ke Sai, Guoxu Ma

    期刊:PHYTOMEDICINE

    DOI:10.1016/j.phymed.2023.155328

    影響因子 :7.900

    引用產(chǎn)品:CL-0184

  • Simultaneous Fluorescence Visualization of Epithelial-Mesenchymal Transition and Apoptosis Processes in Tumor Cells for Evaluating the Impact of Epithelial-Mesenchymal Transition on Drug Efficacy(2018/09/18)

    作者:Mingming Luan, Jinjie Chang, Wei Pan

    期刊:Analytical Chemistry

    DOI:10.1021/acs.analchem.8b02494

    影響因子 :7.400

    引用產(chǎn)品:CL-0150 CL-0184 CL-0525

  • System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma(2022/10/05)

    作者:Cheng Yan, Yandie Niu, Feng Li

    期刊:Journal of Translational Medicine

    DOI:10.1186/s12967-022-03632-z

    影響因子 :7.400

    引用產(chǎn)品:CL-0059 CL-0184

  • Discovery of Novel Coumarin-quinolinium Derivatives as Pan-KRAS Translation Inhibitors by Targeting 5′-UTR RNA G-Quadruplexes(2024/01/25)

    作者:Maolin Li, Letian Dai, Zhuoyu Gao

    期刊:JOURNAL OF MEDICINAL CHEMISTRY

    DOI:10.1021/acs.jmedchem.3c01773

    影響因子 :7.300

    引用產(chǎn)品:CL-0184

  • Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2(2024/01/26)

    作者:Hao Yang, Zhongyi Li, Shiqi Zhu

    期刊:Frontiers in Immunology

    DOI:10.3389/fimmu.2024.1347683

    影響因子 :7.300

    引用產(chǎn)品:CL-0184

  • Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making(2023/03/07)

    作者:Jun Zhu, Yanlong Shi, Sheng Lan

    期刊:APOPTOSIS

    DOI:10.1007/s10495-023-01823-7

    影響因子 :7.200

    引用產(chǎn)品:CL-0184

  • CHES1 modulated tumorigenesis and senescence of pancreas cancer cells through repressing AKR1B10(2024/05/06)

    作者:Demin Kong, Yingying Wu, Binghua Tong

    期刊:BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

    DOI:10.1016/j.bbadis.2024.167214

    影響因子 :6.200

    引用產(chǎn)品:CL-0184

  • 6-Shogaol Exhibits a Promoting Effect with Tax via Binding HSP60 in Non-Small-Cell Lung Cancer(2022/11/19)

    作者:Shulipan Mulati, Rongsong Jiang, Jinfeng Wang, Yicun Tao, Weiyi Zhang

    期刊:Cells

    DOI:10.3390/cells11223678

    影響因子 :6.000

    引用產(chǎn)品:CL-0006 CL-0014 CL-0016 CL-0109 CL-0184 CL-0237 PM150110 PM150210

  • Anti?silencing function 1B promotes the progression of pancreatic cancer by activating c?Myc(2022/11/17)

    作者:Min Zhang, Luyang Zhang, Minghe Zhou

    期刊:INTERNATIONAL JOURNAL OF ONCOLOGY

    DOI:10.3892/ijo.2022.5456

    影響因子 :5.884

    引用產(chǎn)品:CL-0184

  • Upstream stimulatory factor 2 inhibits erastin-induced ferroptosis in pancreatic cancer through transcriptional regulation of pyruvate kinase M2(2022/09/20)

    作者:Meijie Chen, Xuena Li, Bulin Du

    期刊:BIOCHEMICAL PHARMACOLOGY

    DOI:10.1016/j.bcp.2022.115255

    影響因子 :5.800

    引用產(chǎn)品:CL-0027 CL-0042 CL-0059 CL-0184 CL-0448 CL-0627 CM-0059 CM-0448A

  • PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer(2022/12/28)

    作者:Kang Chen, Manxiong Dai, Quanneng Luo

    期刊:INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

    DOI:10.1016/j.biocel.2022.106358

    影響因子 :5.652

    引用產(chǎn)品:CL-0184

  • Deciphering the action mechanism of paeoniflorin in suppressing pancreatic cancer: A network pharmacology study and experimental validation.(2022/10/20)

    作者:Chunhao Cao, Wenting Zhao, Xianglin Chen

    期刊:Frontiers in Pharmacology

    DOI:10.3389/fphar.2022.1032282

    影響因子 :5.600

    引用產(chǎn)品:CL-0184 CL-0709

  • The ALOX5 inhibitor Zileuton regulates tumor-associated macrophage M2 polarization by JAK/STAT and inhibits pancreatic cancer invasion and metastasis(2023/06/20)

    作者:Weimin Hu, Siqing Liu, Kongfan Zhu

    期刊:INTERNATIONAL IMMUNOPHARMACOLOGY

    DOI:10.1016/j.intimp.2023.110505

    影響因子 :5.600

    引用產(chǎn)品:CL-0184

  • LINC00909 up-regulates pluripotency factors and promotes cancer stemness and metastasis in pancreatic ductal adenocarcinoma by targeting SMAD4(2024/03/19)

    作者:Zhenchong Li, Zuyi Ma, Shujie Wang

    期刊:Biology Direct

    DOI:10.1186/s13062-024-00463-4

    影響因子 :5.500

    引用產(chǎn)品:CL-0184

  • 5′-tRF-19-Q1Q89PJZ Suppresses the Proliferation and Metastasis of Pancreatic Cancer Cells via Regulating Hexokinase 1-Mediated Glycolysis(2023/10/12)

    作者:Wenpeng Cao, Zhirui Zeng, Shan Lei

    期刊:Biomolecules

    DOI:10.3390/biom13101513

    影響因子 :5.500

    引用產(chǎn)品:CL-0184

  • Pancreatic stellate cell-derived exosomal tRF-19-PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through AXIN2(2023/07/24)

    作者:Wenpeng Cao, Shisi Dai, Wanyuan Ruan

    期刊:JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

    DOI:10.1111/jcmm.17852

    影響因子 :5.300

    引用產(chǎn)品:CL-0027 CL-0184 CP-H024

  • COL12A1 Acts as a Novel Prognosis Biomarker and Activates Cancer-Associated Fibroblasts in Pancreatic Cancer through Bioinformatics and Experimental Validation(2023/02/26)

    作者:Yao Song, Lei Wang, Kaidong Wang

    期刊:Cancers

    DOI:10.3390/cancers15051480

    影響因子 :5.200

    引用產(chǎn)品:CL-0027 CL-0042 CL-0059 CL-0184 CL-0627

  • Identifying endoplasmic reticulum stress-related molecular subtypes and prognostic model for predicting the immune landscape and therapy response in pancreatic cancer(2023/10/09)

    作者:Biao Zhang, Xu Chen, Zhizhou Wang

    期刊:Aging-US

    DOI:10.18632/aging.205094

    影響因子 :5.200

    引用產(chǎn)品:CL-0184

  • MFG-E8 induces epithelial-mesenchymal transition and anoikis resistance to promote the metastasis of pancreatic cancer cells(2024/02/29)

    作者:Wuming Liu, Yifan Ren, Tao Wang

    期刊:EUROPEAN JOURNAL OF PHARMACOLOGY

    DOI:10.1016/j.ejphar.2024.176462

    影響因子 :5.000

    引用產(chǎn)品:CL-0184

  • A gold–selenium-bonded nanoprobe for real-time in situ imaging of the upstream and downstream relationship between uPA and MMP-9 in cancer cells(2019/03/16)

    作者:Mingming Luan

    期刊:Chem Commun

    DOI:10.1039/c9cc01454c

    影響因子 :4.900

    引用產(chǎn)品:CL-0149 CL-0184

  • A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation(2021/11/22)

    作者:Chao Wu, Zhihong Huang, Ziqi Meng

    期刊:Chinese Medicine

    DOI:10.1186/s13020-021-00534-y

    影響因子 :4.900

    引用產(chǎn)品:CL-0184

  • Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research(2022/01/08)

    作者:Zhenghai Bai, Fangshi Xu, Xiaodan Feng

    期刊:Bioengineered

    DOI:10.1080/21655979.2021.2019873

    影響因子 :4.900

    引用產(chǎn)品:CL-0042 CL-0184

  • Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments(2023/01/14)

    作者:Haojia Wang, Zhishan Wu, Xiaotian Fan

    期刊:Chinese Medicine

    DOI:10.1186/s13020-023-00710-2

    影響因子 :4.900

    引用產(chǎn)品:CL-0184

  • Identification and characterization of interferon-γ signaling-based personalized heterogeneity and therapeutic strategies in patients with pancreatic cancer(2023/10/24)

    作者:Xu Chen, Qihang Yuan, Hewen Guan

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2023.1227606

    影響因子 :4.700

    引用產(chǎn)品:CL-0184

  • Exosomal lncRNA UCA1 Derived From Pancreatic Stellate Cells Promotes Gemcitabine Resistance in Pancreatic Cancer via the SOCS3/EZH2 Axis(2021/11/19)

    作者:Yuan Chi, He Xin, Zhaoyu Liu

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2021.671082

    影響因子 :4.700

    引用產(chǎn)品:CL-0005 CL-0184

  • MiR-24-3p Inhibits the Progression of Pancreatic Ductal Adenocarcinoma Through LAMB3 Downregulation(2020/01/21)

    作者:Wenjie Huang, Jianyou Gu, Tian Tao

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2019.01499

    影響因子 :4.700

    引用產(chǎn)品:CL-0027 CL-0184

  • PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer(2023/07/14)

    作者:Biao Zhang, Bingqian Huang, Xiaonan Zhang

    期刊:Frontiers in Oncology

    DOI:10.3389/fonc.2023.1217654

    影響因子 :4.700

    引用產(chǎn)品:CL-0059 CL-0184

  • Effects of anoxic prognostic model on immune microenvironment in pancreatic cancer(2023/06/05)

    作者:Yangdong Wu, Qingyan Kou, Lin Sun

    期刊:Scientific Reports

    DOI:10.1038/s41598-023-36413-9

    影響因子 :4.600

    引用產(chǎn)品:CL-0184

  • Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer(2022/11/09)

    作者:Zhenchong Li, Zuyi Ma, Qi Zhou, Shujie Wang, Qian Yan, Hongkai Zhuang, Zixuan Zhou, Chunsheng Liu, Zhongshi Wu, Jinglin Zhao, Shanzhou Huang, Chuanzhao Zhang, Baohua Hou

    期刊:Heliyon

    DOI:10.1016/j.heliyon.2022.e11321

    影響因子 :4.000

    引用產(chǎn)品:CL-0184

  • GPR120 promotes metastasis but inhibits tumor growth in pancreatic ductal adenocarcinoma(2022/06/05)

    作者:Xiaoyuan Sun, Huijun Chu, Ke Lei

    期刊:PANCREATOLOGY

    DOI:10.1016/j.pan.2022.06.006

    影響因子 :3.977

    引用產(chǎn)品:CL-0027 CL-0042 CL-0184 CL-0627

  • CMTM3 Overexpression Predicts Poor Survival and Promotes Proliferation and Migration in Pancreatic Cancer(2021/08/03)

    作者:Zixuan Zhou,?Zuyi Ma,?Zhenchong Li

    期刊:Journal of Cancer

    DOI:10.7150/jca.57082

    影響因子 :3.900

    引用產(chǎn)品:CL-0027 CL-0042 CL-0184 CL-0448 CL-0709

  • Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut microbial homeostasis(2023/10/30)

    作者:Zemin Zhu, Bo Yi, Zikai Tang

    期刊:BMC CANCER

    DOI:10.1186/s12885-023-11557-z

    影響因子 :3.800

    引用產(chǎn)品:CL-0184

  • TFAP2A-induced SLC2A1-AS1 promotes cancer cell proliferation(2021/2/19)

    作者:Yuanbo Cui, Chunyan Zhang, Shanshan Ma

    期刊:Biological Chemistry

    DOI:10.1515/hsz-2020-0290

    影響因子 :3.700

    引用產(chǎn)品:CL-0184 CL-0213

  • ITGB6 promotes pancreatic fibrosis and aggravates the malignant process of pancreatic cancer via JAK2/STAT3 signaling pathway(2024/02/28)

    作者:Yu Zhang, Zhiyuan Chen, Zhengchao Shen

    期刊:NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

    DOI:10.1007/s00210-024-03003-z

    影響因子 :3.600

    引用產(chǎn)品:CL-0184

  • Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway(2020/3/10)

    作者:Xiangpeng Meng, Jia Ma, Baosheng Wang

    期刊:Journal Of Physiology And Biochemistry

    DOI:10.1007/s13105-020-00734-4

    影響因子 :3.400

    引用產(chǎn)品:CL-0027 CL-0042 CL-0184

  • Cancer-associated fibroblast-secreted miR-421 promotes pancreatic cancer by regulating the SIRT3/H3K9Ac/HIF-1α axis(2022/10/06)

    作者:Bin Zhou, Jinghao Lei, Qiang Wang

    期刊:KAOHSIUNG JOURNAL OF MEDICAL SCIENCES

    DOI:10.1002/kjm2.12590

    影響因子 :3.300

    引用產(chǎn)品:164210 CL-0027 CL-0184 PB180120 PM150110 PM150210

  • Circadian Genes MBOAT2/CDA/LPCAT2/B4GALT5 in the Metabolic Pathway Serve as New Biomarkers of PACA Prognosis and Immune Infiltration(2023/04/30)

    作者:Qingqing Wang, Shuning Zhou, Xinyi Hu

    期刊:Life-Basel

    DOI:10.3390/life13051116

    影響因子 :3.200

    引用產(chǎn)品:CL-0184 PM150210

  • FAM53B promotes pancreatic ductal adenocarcinoma metastasis by regulating macrophage M2 polarization(2024/04/15)

    作者:Xuanzeng Pei, Min Cai, Dawei Jiang

    期刊:World Journal of Gastrointestinal Oncology

    DOI:10.4251/wjgo.v16.i4.1479

    影響因子 :3.000

    引用產(chǎn)品:CL-0184

  • Transcriptome analysis of pancreatic cancer cell response to treatment with grape seed proanthocyanidins(2018/12/6)

    作者:Weihua Wang, Leilei Zhan, Dongqi Guo

    期刊:Oncology Letters

    DOI:10.3892/ol.2018.9807

    影響因子 :2.900

    引用產(chǎn)品:CL-0184

  • Pancreatic cancer cell apoptosis is induced by a proteoglycan extracted from Ganoderma lucidum(2020/11/12)

    作者:Xiao Wu, Liping Jiang, Zeng Zhang

    期刊:Oncology Letters

    DOI:10.3892/ol.2020.12295

    影響因子 :2.900

    引用產(chǎn)品:CL-0103 CL-0184

  • A prospective prognostic signature for pancreatic adenocarcinoma based on ubiquitination-related mRNA-lncRNA with experimental validation in vitro and vivo(2023/08/04)

    作者:Zhizhou Wang, Qihang Yuan, Xu Chen

    期刊:FUNCTIONAL & INTEGRATIVE GENOMICS

    DOI:10.1007/s10142-023-01158-1

    影響因子 :2.900

    引用產(chǎn)品:CL-0059 CL-0184

  • Grape seed proanthocyanidins inhibit proliferation of pancreatic cancer cells by modulating microRNA expression(2019/1/4)

    作者:Weihua Wang, Leilei Zhan, Dongqi Guo

    期刊:Oncology Letters

    DOI:10.3892/ol.2019.9887

    影響因子 :2.900

    引用產(chǎn)品:CL-0184

  • Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer(2021/7/22)

    作者:Jilong Hu, Zhinan Zheng, Jia Lei

    期刊:PPAR Research

    DOI:10.1155/2021/5589342

    影響因子 :2.900

    引用產(chǎn)品:CL-0027 CL-0184

  • Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer(2023/02/12)

    作者:Jiaxing Du, Yongsheng Chen, Genglong Liu

    期刊:PATHOLOGY RESEARCH AND PRACTICE

    DOI:10.1016/j.prp.2023.154374

    影響因子 :2.800

    引用產(chǎn)品:CL-0027 CL-0042 CL-0184 CL-0627

  • GPX3 represses pancreatic cancer cell proliferation, migration and invasion, and improves their chemo?sensitivity by regulating the JNK/c?Jun signaling pathway(2024/01/29)

    作者:Ye Ma, Lixing Zhang, Xin Gao

    期刊:Experimental and Therapeutic Medicine

    DOI:10.3892/etm.2024.12407

    影響因子 :2.700

    引用產(chǎn)品:CL-0184

  • Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.(2022/10/01)

    作者:Tong Wu, Tianyang Qian, Renjie Lin

    期刊:Journal of Gastrointestinal Oncology

    DOI:10.21037/jgo-22-941

    影響因子 :2.587

    引用產(chǎn)品:CL-0184

  • Identification of a Pyroptosis-Related Gene Signature and Effect of Silencing the CHMP4C and CASP4 in Pancreatic Adenocarcinoma(2022/11/14)

    作者:Yajun Chen, Yiming Liu, Menghao Wang

    期刊:International Journal of General Medicine

    DOI:10.2147/IJGM.S353849

    影響因子 :2.145

    引用產(chǎn)品:CL-0184

  • Knockdown of interferon-induced transmembrane protein 1 inhibited proliferation, induced cell cycle arrest and apoptosis, and suppressed MAPK signaling pathway in pancreatic cancer cells(2020/5/20)

    作者:Lei Zhang, Zhenyong Wang, Deshuai Kong

    期刊:Bioscience Biotechnology And Biochemistry

    DOI:10.1080/09168451.2020.1762479

    影響因子 :1.600

    引用產(chǎn)品:CL-0027 CL-0184

  • 點(diǎn)擊展開(kāi)收起列表
FAQs

Q:{{item.question}}

A:

暫無(wú)數(shù)據(jù)
產(chǎn)品資料
注:百度瀏覽器無(wú)法支持掃一掃功能,請(qǐng)輸入識(shí)別碼,獲取相應(yīng)產(chǎn)品資料

識(shí)別碼示意圖

確定
邱國(guó)娜/胡文君

邱國(guó)娜/胡文君

【 上海 】

何帆

何帆

【 陜西、甘肅、寧夏、青海、新疆 】

 熊經(jīng)理

熊經(jīng)理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

劉本佳

劉本佳

【江蘇(除南京外)】

章臣雄

章臣雄

【 廣州 】

杜焱煒

杜焱煒

【 四川、云南、西藏 】

田博浩

田博浩

【 重慶、貴州 】

石文平

石文平

【 北京、遼寧 】

胡文君

胡文君

【江西】

李榮楓

李榮楓

【 天津、河北、內(nèi)蒙古、山西 】

陳雨蘭

陳雨蘭

【 山東 】

尹國(guó)文

尹國(guó)文

【浙江】

唐小花

唐小花

【 吉林、黑龍江 】

付帥

付帥

【 安徽 】

朱俊宇

朱俊宇

【 河南、廣西 】

李慶祖

李慶祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文強(qiáng)

梅文強(qiáng)

【福建】

林釗光

林釗光

【南京】

微信掃一掃咨詢

微信掃一掃咨詢

在線客服
關(guān)閉
在線咨詢
聯(lián)系銷售

關(guān)注微信公眾號(hào)